Table 1.
Baseline characteristics of patients in each group before the spontaneous breathing trial.
| PS (19) | ATC (17) | P value | |
|---|---|---|---|
| Sex: | |||
| Female: number (%) | 6 (31.6%) | 7 (41.2%) | 0.549 |
| Male: number (%) | 13 (68.4%) | 10 (58.8%) | |
| Age (yrs): median (range) | 0.83 (0.08–13) | 1.25 (0.33–8) | 0.068 |
| Cause of mechanical ventilation (MV): | |||
| Acute respiratory failure: number (%) | 12 (63.2%) | 5 (29.4%) | |
| Neurological dysfunction: number (%) | 3 (15.8%) | 8 (47.1%) | 0.08 |
| Shock and sepsis: number (%) | 4 (21.1%) | 4 (23.5%) | |
| MV* duration before trial: median (range) | 7 (2–40) | 11 (3–30) | 0.260 |
| Pretrial rate: median (range) | 10 (5–30) | 8 (4–20) | 0.150 |
| Pretrial FIO2: mean ± SD* | 40.53 ± 5.24 | 42.65 ± 6.15 | 0.272 |
| Pretrial OI*: mean ± SD* | 2 ± 1.05 | 2.24 ± 1.47 | 0.539 |
| Bronchodilators: number (%) | 10 (52.6%) | 7 (41.2%) | 0.492 |
| PRISM III score* on day 1 admission: mean ± SD* | 19.53 ± 10 | 20.24 ± 10.2 | 0.787 |
*MV: mechanical ventilation.
*SD: standard deviation.
*PRISM III score: pediatric risk of mortality score.
*OI: oxygenation index.